Pharming (PHAR) FCF Margin (2020 - 2025)
Pharming's (PHAR) quarterly FCF Margin came in at 10.76% in Q4 2025, up 49145330.0% YoY from N/an in Q4 2024, and up 100.0% on a QoQ basis from 491442.54% in Q4 2024.
Pharming (PHAR) FCF Margin (2020 - 2025) Analysis & Trends
Pharming (PHAR) has 6 years of FCF Margin data on file, last reported at 10.76% in Q4 2025.
- Quarterly FCF Margin rose 49145330.0% year-over-year to 10.76% in Q4 2025, while the trailing twelve-month figure through Jun 2026 was 3.13% (down 838.0% YoY) and the FY2025 annual result came in at 14.35%, up 1522.0% from the prior year.
- FCF Margin improved to 10.76% in Q4 2025, from 491442.54% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 13513368.98% in Q3 2024 to a low of 19538177.34% in Q4 2023.
- A 5-year average of 651619.59% and a median of 3.03% in 2022 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2023 — FCF Margin plunged 1953817788 bps — and 2024, when it surged 1904673480 bps.
- Tracing PHAR's FCF Margin over 5 years: stood at 0.03% in 2021, then soared by 1708 bps to 0.54% in 2022, then slumped by 2000000000 bps to 19538177.34% in 2023, then soared by 97 bps to 491442.54% in 2024, then soared by 100 bps to 10.76% in 2025.
- The last three FCF Margin figures came in at 10.76% (Q4 2025), 491442.54% (Q4 2024), and 13513368.98% (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Pharming | 824.47 Mn | 666.19 Mn | 141.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.76% |
| Dec 31, 2024 | -491,442.54% |
| Sep 30, 2024 | 13,513,368.98% |
| Dec 31, 2023 | -19,538,177.34% |
| Sep 30, 2023 | 5.51% |
| Jun 30, 2023 | 0.00% |
| Dec 31, 2022 | 0.54% |
| Sep 30, 2022 | 23.91% |
| Dec 31, 2021 | -0.03% |
| Sep 30, 2021 | 14.30% |
| Dec 31, 2020 | 0.09% |
| Sep 30, 2020 | 32.58% |